跳至主要内容
临床试验/NCT06310252
NCT06310252已完成不适用

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Intrastromal Implantation of the Transform Corneal Allograft (TCA) for Providing Near Vision in Presbyopic Subjects - Long Term Follow-up

Allotex, Inc.5 个研究点 分布在 4 个国家目标入组 71 人开始时间: 2024年2月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Allotex, Inc.
入组人数
71
试验地点
5
主要终点
An exploratory data collection project with no primary safety or effectiveness endpoints.

研究概览

简要总结

The objective of this clinical study is to evaluate the long term safety and effectiveness of intrastromal implantation of the Allotex TransForm corneal allograft (TCA) for providing near vision in presbyopic subjects.

A maximum of 101 eyes of qualified and consented subjects will undergo long term follow-up after instrastromal implantation of the TCA for presbyopia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Provide informed consent, have signed the written informed consent form, and been given a copy.
  • Subjects must be willing and able to return for one scheduled follow-up examinations.
  • Subjects must have undergone implantation with the TCA under study protocol PRO-010 between April 24, 2019 and October 31, 2019.

排除标准

  • There are no known exclusion criteria.

结局指标

主要结局

An exploratory data collection project with no primary safety or effectiveness endpoints.

时间窗: 4 years or more after TCA implantation

An exploratory data collection project with no primary safety or effectiveness endpoints.

次要结局

未报告次要终点

研究者

发起方
Allotex, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验